Socialite and reality TV star Kim Kardashian was ordered by the U.S. Food and Drug Administration to correct her advertisement for Diclegis, a morning sickness drug she promoted to her social media followers. The FDA took issue with Kardashian failing to fully disclose known risks and side effects associated with morning sickness drugs, including birth defects.
Kardashian reported that she began taking the drug to combat morning sickness after being advised by her doctor. Morning sickness drugs have had a turbulent history beginning with the German-made thalidomide, a drug that ultimately led to the disfiguring and deaths of thousands of infants.
Anti-nausea drug Zofran has also increasingly been used to treat morning sickness, despite not being approved by the FDA for the use. Zofran is only intended for use in post-surgery and cancer patients, though manufacturer GlaxoSmithKline has allegedly promoted the drug for off-label usage for morning sickness in pregnant women.
Women who used Zofran during pregnancy and gave birth to a child with birth defects are coming forward. Multiple Zofran lawsuits have been filed against GlaxoSmithKline alleging that the company failed to disclose the increased risks of birth defects associated with the morning sickness drug.